A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy

NCT02752048 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Duchenne Muscular Dystrophy

Interventions

DRUG: TAS-205
DRUG: Placebo

Sponsor

Taiho Pharmaceutical Co., Ltd.